undamentalytics Newsletter

Imagenebio, Inc. valuation and forecast

Explore the models for Imagenebio, Inc., adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: every model's value for Imagenebio, Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Analyst recommendations

4 analysts, Oct 2026
Buy375%
Hold00%
Sell125%

Monthly trend

  1. Oct 2026314
  2. Sep 2026213

Counts of recommendations published by analysts covering Imagenebio, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Price history

Loading chart…

Third-party market data · may be delayed

IMA valuation questions

How does Fundamentalytics value Imagenebio, Inc.?
We use the models that fit Imagenebio, Inc.'s business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Imagenebio, Inc.

Compare with peers